KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Treasury Shares (2016 - 2025)

Opko Health's Treasury Shares history spans 16 years, with the latest figure at $3.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 77.33% year-over-year to $3.2 million; the TTM value through Dec 2025 reached $3.2 million, up 77.33%, while the annual FY2025 figure was $3.2 million, 77.33% up from the prior year.
  • Treasury Shares reached $60.4 million in Q4 2025 per OPK's latest filing, up from $10.7 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $70.0 million in Q3 2024 to a low of -$29.8 million in Q2 2024.
  • Average Treasury Shares over 5 years is $4.7 million, with a median of $8.7 million recorded in 2021.
  • Peak YoY movement for Treasury Shares: changed 0.0% in 2021, then surged 77.33% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then changed by 0.0% to $1.8 million in 2024, then soared by 77.33% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Treasury Shares are $3.2 million (Q4 2025), $2.4 million (Q3 2025), and $1.8 million (Q2 2025).